Cis Biopharma

Oncology that carries responsibility. At CIS BIOPHARMA, we design the next generation of cancer therapies - targeted treatments that deliver maximum effect directly to tumor cells while minimizing harm to healthy tissue. Our focus Antibody-Drug Conjugates (ADCs)- smarter chemotherapy Radiopharmaceuticals - targeted radiation from within Where standard therapies reach their limits, we create innovative solutions that matter For partners, who seek to expand their oncology portfolio For investors, who look for sustainable value in breakthrough science For scientists, who want to advance research on unique targets like L1CAM What sets us apart? We combine cutting-edge science with a proven track record in oncology drug development and work closely with partners who share our mission to transform cancer care. Our strengths at a glance • Unique tumor targets such as L1CAM • In-house Swiss labs for speed & quality • Proprietary chemistry & AI-driven protein engineering